From: Spatial analysis of vaccine coverage on the first year of life in the northeast of Brazil
2016 | 2017 | p value | |||
---|---|---|---|---|---|
N | % | N | % | ||
Bacillus Calmette–Guérin | |||||
Very low (0–50) | 110 | 49.3 | 104 | 46.6 | |
Low (50–90) | 61 | 27.4 | 66 | 29.6 | 0.942 |
Adequate (90–120) | 34 | 15.2 | 34 | 15.2 | |
High (> 120) | 18 | 8.1 | 19 | 8.5 | |
Hepatitis B | |||||
Very low (0–50) | 7 | 3.1 | 5 | 2.2 | |
Low (50–95) | 106 | 47.5 | 136 | 61.0 | 0.004 |
Adequate (95–120) | 77 | 34.5 | 69 | 30.9 | |
High (> 120) | 33 | 14.8 | 13 | 5.8 | |
Haemophilus influenzae type B | |||||
Very low (0–50) | 8 | 3.6 | 5 | 2.2 | |
Low (50–95) | 105 | 47.1 | 136 | 61.0 | 0.004 |
Adequate (95–120) | 78 | 35.0 | 69 | 30.9 | |
High (> 120) | 32 | 14.3 | 13 | 5.8 | |
Diphtheria–Tetanus–Pertussis | |||||
Very low (0–50) | 8 | 3.6 | 5 | 2.2 | |
Low (50–95) | 105 | 47.1 | 136 | 61.0 | 0.004 |
Adequate (95–120) | 78 | 35.0 | 69 | 30.9 | |
High (> 120) | 32 | 14.3 | 13 | 5.8 | |
Poliomyelitis | |||||
Very low (0–50) | 9 | 4.0 | 2 | 0.9 | |
Low (50–95) | 105 | 47.1 | 137 | 61.4 | 0.001 |
Adequate (95–120) | 66 | 29.6 | 67 | 30.0 | |
High (> 120) | 43 | 19.3 | 17 | 7.6 | |
Rotavirus | |||||
Very low (0–50) | 7 | 3.1 | 4 | 1.8 | |
Low (50–90) | 68 | 30.5 | 95 | 42.6 | 0.004 |
Adequate (90–120) | 121 | 54.3 | 114 | 51.1 | |
High (> 120) | 27 | 12.1 | 10 | 4.5 | |
Pneumococcus | |||||
Very low (0–50) | 4 | 1.8 | 3 | 1.3 | |
Low (50–95) | 77 | 34.5 | 107 | 48.0 | 0.008 |
Adequate (95–120) | 104 | 46.6 | 94 | 42.2 | |
High (> 120) | 38 | 17.0 | 19 | 8.5 | |
Meningococcus | |||||
Very low (0–50) | 7 | 3.1 | 3 | 1.3 | |
Low (50–95) | 91 | 40.8 | 125 | 56.1 | 0.002 |
Adequate (95–120) | 95 | 42.6 | 82 | 36.8 | |
High (> 120) | 30 | 13.5 | 13 | 5.8 |